Literature DB >> 15996478

Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.

Naoko Yamada1, Tohru Tsujimura, Haruyasu Ueda, Shin-Ichi Hayashi, Hideki Ohyama, Haruki Okamura, Nobuyuki Terada.   

Abstract

Macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-kappaB ligand (RANKL) induce the differentiation of bone marrow macrophages (BMMs) into osteoclasts. To delineate mechanisms involved, the effect of M-CSF on the production of osteoprotegerin (OPG), decoy receptor of RANKL, in BMMs was investigated. Mouse bone marrow cells were cultured with M-CSF for 4 days and adherent cells formed were used as BMMs. BMMs were cultured with or without M-CSF, and analyzed for expression of OPG and receptor activator of NF-kappaB (RANK; receptor for RANKL) mRNAs by real-time polymerase chain reaction and secretion of OPG by enzyme-linked immunosorbent assay. BMMs expressed macrophage markers, CD115 (c-fms), Mac-1 and F4/80, and showed phagocytotic activity. In addition, BMMs expressed OPG mRNA and secreted OPG into medium. M-CSF inhibited both the OPG mRNA expression and the OPG secretion dose-dependently and reversibly. The expression of RANK mRNA was not significantly affected by M-CSF. The results showed that M-CSF suppresses the OPG production in BMMs, which may increase the sensitivity of BMMs to RANKL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996478     DOI: 10.1016/j.cyto.2005.03.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway.

Authors:  Laura Y Lu; Florence Loi; Karthik Nathan; Tzu-Hua Lin; Jukka Pajarinen; Emmanuel Gibon; Akira Nabeshima; Luis Cordova; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Orthop Res       Date:  2017-03-13       Impact factor: 3.494

2.  OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.

Authors:  Munehisa Shimamura; Hironori Nakagami; Mariana K Osako; Hitomi Kurinami; Hiroshi Koriyama; Pang Zhengda; Hideki Tomioka; Akiko Tenma; Kouji Wakayama; Ryuichi Morishita
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-20       Impact factor: 11.205

Review 3.  HIV and bone loss.

Authors:  Shitij Arora; Manasi Agrawal; Li Sun; Frantz Duffoo; Mone Zaidi; Jameel Iqbal
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

4.  Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.

Authors:  Behnam Eslami; Shuanhu Zhou; Inge Van Eekeren; Meryl S LeBoff; Julie Glowacki
Journal:  Calcif Tissue Int       Date:  2011-02-15       Impact factor: 4.333

Review 5.  Macrophage colony-stimulating factor in the pathogenesis of HIV infection: potential target for therapeutic intervention.

Authors:  Valerie Haine; Tracy Fischer-Smith; Jay Rappaport
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

6.  FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2).

Authors:  Dawei Zhang; Yongjun Huang; Zongwen Huang; Rongkai Zhang; Honggang Wang; Dong Huang
Journal:  Med Sci Monit       Date:  2016-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.